Anti-CD20 (Rituximab), Chimeric Antibody

(No reviews yet) Write a Review
SKU:
A1049-100
£318.30
Frequently bought together:

Description

Anti-CD20 (Rituximab), Chimeric Antibodyis available at Gentaur for Next week Delivery.

Description: Rituximab, a chimeric monoclonal antibody targeted against the pan-B-cell marker CD20. Mechanisms of cell destruction that have been demonstrated to be activated by rituximab binding to CD20 include direct signaling of apoptosis, complement activation and antibody dependent cellular cytotoxicity. Rituximab is a mainstay in the therapy for a broad variety of B-cell malignancies.

Immunogen Sequence:CD20

Target Alternative Name:MabThra

Species Reactivities:Human

Tag Line:Monoclonal human IgG1 antibody against human CD20

Formulation:100 ug (2 mg/ml) of antibody in Phosphate buffered saline, pH 7.4.

Purification: human IgG1 was expressed in a human cell line. IgG was purified from CHO cell culture supernatant by protein A chromatography.

Application:Neutralization, ELISA

Positive Control:/

Application And Usages:Activation : 1-20 μg/ml; ELISA: 2μg/ml

Handling:The antibody solution should be gently mixed before use

View AllClose

Additional Information

Size:
100 µg
Antibody Target:
CD20
Category:
Human IgG monoclonal antibodies
Host:
Human/Mouse chimeric
Antibody Type:
Monoclonal
Isotype:
Human IgG1
Accession Number:
NP_690605
Gene Id:
54474
Concentration:
2 mg/ml
Appearance:
Colourless liquid
Form:
Liquid
Storage Condition:
-20°C
Shipping Condition:
gel pack
Shelf Life:
12 months
Country of Animal Origin:
USA
Country of Manufacture:
USA
Usage:
For Research Use Only! Not to be used in humans
Western Blot Verified:
Not Verified
Immunocytochemistry Verified:
Not Verified
Immunofluorescence Verified:
Not Verified
Immunoprecipitation Verified:
Not Verified
ELISA Verified:
Not Verified
ChIP Verified:
Not Verified
Dot Blot Verified:
Not Verified
Flow Cytometry Verified:
Not Verified
View AllClose

0 Reviews

View AllClose